Tenovi’s FDA-Cleared Blood Pressure Monitor Advances Maternal Health and Stroke Prevention

Connected monitoring device brings real-time, remote care support for pregnant patients and individuals at cardiovascular risk.

Tenovi has launched a new FDA-cleared cellular-connected blood pressure monitor designed to improve preventive care for high-risk patients, particularly in maternal health and stroke prevention. The device features irregular heartbeat detection and is compatible with Tenovi’s large-size cuff, making it suitable for a wide range of adult patients—including those with diabetes, pregnancy-related hypertension, or preeclampsia. As part of Tenovi’s remote patient monitoring (RPM) platform, this innovation allows for real-time data transmission without the need for apps, Wi-Fi, or syncing, ensuring seamless integration into both home and clinical environments.

The device connects through Tenovi’s proprietary Cellular Gateway, which supports over 40 FDA-cleared Bluetooth devices for continuous monitoring of vital signs, medication adherence, and physical activity. Its user-friendly design features a simple red-green LED system: a red light prompts the patient to take a reading, and a green light confirms the transmission of the data to their care team. This plug-and-play RPM system ensures better compliance and enhances early detection of rising blood pressure or irregularities, enabling clinicians to intervene before complications such as stroke occur.

Launched during National Stroke Awareness Month, Tenovi’s latest solution underscores its commitment to accessible, proactive healthcare. With stroke often linked to unmanaged hypertension, and chronic illnesses affecting over 129 million Americans, this technology addresses a critical gap in long-term patient monitoring. By supporting early intervention through a scalable, senior-friendly RPM platform, Tenovi is empowering providers and patients alike to improve outcomes and reduce preventable emergencies.


MedTech Spectrum's Summary

Enhanced Preventive Care : Tenovi’s FDA-cleared cellular blood pressure monitor with irregular heartbeat detection enables early identification of stroke risk, especially in patients with conditions like pregnancy-related hypertension and diabetes.

Seamless Remote Monitoring : The device integrates into Tenovi’s RPM platform, requiring no apps or Wi-Fi, and uses a simple LED system—making it accessible for seniors and improving adherence to daily monitoring routines.

Commitment to Proactive Health : Launched during Stroke Awareness Month, this innovation reinforces Tenovi’s mission to close care gaps, reduce preventable complications, and improve long-term outcomes for high-risk populations.